Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.31 trillion and total revenue of $119.75 billion.
Market Cap
1.31T
Revenue
119.75B
Profits
-33.33B
PE Ratio
n/a
Profit Margin
-27.83%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 141.65B | 3.50% | 3,038,079 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 93.11B | 13.33% | 2,851,707 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 88.52B | -0.47% | 9,025,344 | 2.23B |
| 4 | ARGX | argenx SE | 56.37B | -0.55% | 462,431 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 42.11B | -0.33% | 292,815 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 41.00B | 0.55% | 1,100,516 | - |
| 7 | RPRX | Royalty Pharma plc | 38.63B | 1.90% | 4,662,117 | 2.54B |
| 8 | GMAB | Genmab A/S | 34.92B | 1.01% | 8,648,924 | 4.13B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.66B | -1.63% | 4,574,466 | 7.53M |
| 10 | INSM | Insmed Incorporated | 24.70B | 0.89% | 5,184,490 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.54B | 3.07% | 2,840,253 | 6.01B |
| 12 | BNTX | BioNTech SE | 22.15B | -1.08% | 631,817 | 3.03B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 22.10B | -5.17% | 7,056,825 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 16.93B | 4.82% | 5,071,811 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 16.50B | -0.68% | 386,641 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 14.86B | -0.21% | 1,402,396 | 1.66B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.60B | 5.97% | 5,770,968 | 945.54M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 14.02B | 3.92% | 1,215,113 | 4.60B |
| 19 | SMMT | Summit Therapeutics Inc. | 12.82B | -1.05% | 3,508,017 | - |
| 20 | TECH | Bio-Techne Corporation | 11.39B | -0.07% | 2,565,840 | 1.22B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.33B | 1.77% | 2,273,689 | 3.41B |
| 22 | KYMR | Kymera Therapeutics, Inc. | 10.81B | 3.29% | 1,591,304 | 102.24M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.94B | -0.31% | 251,524 | 1.28B |
| 24 | KRYS | Krystal Biotech, Inc. | 9.84B | 2.38% | 330,298 | 440.48M |
| 25 | PCVX | Vaxcyte, Inc. | 9.76B | -0.93% | 1,714,490 | - |
| 26 | CAI | Caris Life Sciences, Inc. | 9.70B | -5.01% | 3,672,885 | 989.61M |
| 27 | TWST | Twist Bioscience Corporation | 9.58B | -11.92% | 3,399,915 | 431.80M |
| 28 | PTGX | Protagonist Therapeutics, Inc. | 9.37B | 0.35% | 322,552 | 281.99M |
| 29 | SYRE | Spyre Therapeutics, Inc. | 9.02B | -2.43% | 661,126 | - |
| 30 | IBRX | ImmunityBio, Inc. | 8.79B | -5.15% | 8,960,344 | 165.79M |
| 31 | CORT | Corcept Therapeutics Incorporated | 8.77B | -5.62% | 1,429,019 | 830.81M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.76B | -0.51% | 1,257,102 | 67.67M |
| 33 | TGTX | TG Therapeutics, Inc. | 8.68B | 5.34% | 2,856,055 | 799.54M |
| 34 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.46B | -0.98% | 1,124,504 | 669.50M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 7.98B | -0.93% | 306,363 | 7.46M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.69B | -2.77% | 843,010 | 5.33M |
| 37 | AXSM | Axsome Therapeutics, Inc. | 7.57B | 0.68% | 2,172,346 | 776.57M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.23B | -1.96% | 1,521,918 | 874.09M |
| 39 | LGND | Ligand Pharmaceuticals Incorporated | 6.43B | 1.71% | 344,294 | 306.90M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 6.41B | 0.23% | 633,928 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.37B | -0.54% | 431,656 | 239.92M |
| 42 | BLTE | Belite Bio, Inc | 6.23B | 2.97% | 234,882 | - |
| 43 | KOD | Kodiak Sciences Inc. | 6.22B | -1.22% | 567,756 | - |
| 44 | IMVT | Immunovant, Inc. | 6.03B | -1.59% | 1,165,416 | - |
| 45 | MANE | Veradermics, Incorporated | 5.84B | -2.89% | 464,903 | - |
| 46 | CGON | CG Oncology, Inc. | 5.73B | 1.91% | 870,310 | 6.23M |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 5.52B | -1.61% | 673,429 | 618.07M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.38B | -2.94% | 2,495,030 | - |
| 49 | SRRK | Scholar Rock Holding Corporation | 5.35B | -0.63% | 769,807 | - |
| 50 | ERAS | Erasca, Inc. | 5.02B | -4.21% | 3,749,381 | - |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.01B | -6.97% | 2,357,636 | 1.16B |
| 52 | CRSP | CRISPR Therapeutics AG | 4.97B | -5.23% | 1,167,706 | 13.39M |
| 53 | DFTX | Definium Therapeutics, Inc. | 4.88B | -4.29% | 1,076,283 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.75B | -0.36% | 1,140,511 | 591.33M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.61B | -0.39% | 496,882 | 1.90M |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.22B | -0.03% | 967,476 | - |
| 57 | LEGN | Legend Biotech Corporation | 4.19B | -3.00% | 2,189,554 | 1.27B |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 4.03B | 0.31% | 1,883,904 | 463.98M |
| 59 | RLAY | Relay Therapeutics, Inc. | 4.02B | -5.75% | 3,596,142 | 10.35M |
| 60 | ABCL | AbCellera Biologics Inc. | 3.98B | -6.19% | 3,876,422 | 66.17M |
| 61 | IOVA | Iovance Biotherapeutics, Inc. | 3.84B | -11.30% | 31,202,207 | 324.97M |
| 62 | TNGX | Tango Therapeutics, Inc. | 3.83B | 0.84% | 5,279,085 | 53.81M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.62B | -0.35% | 1,112,366 | 7.50M |
| 64 | IRON | Disc Medicine, Inc. | 3.59B | -2.41% | 684,912 | - |
| 65 | ACAD | Acadia Pharmaceuticals Inc. | 3.55B | -0.82% | 1,137,497 | 1.14B |
| 66 | PBLS | Parabilis Medicines, Inc. | 3.50B | -1.32% | 813,911 | 148.00K |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.48B | 1.56% | 5,143,535 | - |
| 68 | CELC | Celcuity Inc. | 3.38B | -0.25% | 700,003 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.28B | 0.88% | 588,544 | 606.33M |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.24B | -1.84% | 1,236,948 | - |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.14B | -4.31% | 341,881 | 890.79M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.12B | -2.05% | 1,449,768 | - |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | -2.83% | 838,031 | 234.13M |
| 74 | DNLI | Denali Therapeutics Inc. | 3.03B | -1.97% | 1,304,033 | 3.60M |
| 75 | NRIX | Nurix Therapeutics, Inc. | 2.93B | -1.18% | 2,311,431 | 701.94M |
| 76 | VRDN | Viridian Therapeutics, Inc. | 2.79B | -0.52% | 1,710,583 | 71.13M |
| 77 | ZLAB | Zai Lab Limited | 2.74B | -1.30% | 637,837 | 449.61M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.72B | -5.58% | 1,500,244 | 156.04M |
| 79 | MBX | MBX Biosciences, Inc. | 2.69B | 2.44% | 667,264 | - |
| 80 | RCUS | Arcus Biosciences, Inc. | 2.62B | -2.26% | 1,935,907 | 117.00M |
| 81 | ADMA | ADMA Biologics, Inc. | 2.56B | -2.89% | 2,460,825 | 512.28M |
| 82 | PGEN | Precigen, Inc. | 2.48B | 4.52% | 8,104,464 | 85.72M |
| 83 | RXRX | Recursion Pharmaceuticals, Inc. | 2.41B | -4.95% | 24,414,424 | 54.86M |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 2.40B | -3.37% | 1,141,095 | 7.12M |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.36B | 0.70% | 777,437 | 158.00K |
| 86 | PHVS | Pharvaris N.V. | 2.35B | -0.15% | 1,481,525 | - |
| 87 | BHVN | Biohaven Ltd. | 2.33B | -6.49% | 3,164,689 | - |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 0.44% | 871,473 | 959.90M |
| 89 | VERA | Vera Therapeutics, Inc. | 2.23B | 1.47% | 1,083,959 | - |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | -3.25% | 960,797 | 321.74M |
| 91 | XNCR | Xencor, Inc. | 2.22B | 2.09% | 1,289,591 | 104.97M |
| 92 | PVLA | Palvella Therapeutics, Inc. | 2.11B | -3.58% | 292,822 | - |
| 93 | IMNM | Immunome, Inc. | 2.07B | -0.44% | 1,270,813 | 4.02M |
| 94 | LKFT | Lakefront Biotherapeutics NV | 2.07B | -0.15% | 164,054 | 1.13B |
| 95 | MESO | Mesoblast Limited | 2.06B | -3.25% | 375,986 | 120.25M |
| 96 | VCEL | Vericel Corporation | 2.06B | -6.18% | 598,717 | 306.30M |
| 97 | FTRE | Fortrea Holdings Inc. | 2.05B | -7.99% | 2,873,452 | 2.67B |
| 98 | SEPN | Septerna, Inc. | 2.05B | -2.72% | 223,449 | 98.88M |
| 99 | ZYME | Zymeworks Inc. | 2.03B | -0.35% | 2,880,103 | 37.13M |
| 100 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.03B | -7.68% | 1,703,904 | 208.78M |
| 101 | SRPT | Sarepta Therapeutics, Inc. | 1.97B | -3.17% | 1,318,156 | 1.97B |
| 102 | SLS | SELLAS Life Sciences Group, Inc. | 1.95B | -4.72% | 6,263,155 | - |
| 103 | COAG | Hemab Therapeutics Holdings, Inc. | 1.94B | 2.55% | 765,549 | - |
| 104 | TRVI | Trevi Therapeutics, Inc. | 1.93B | -1.81% | 1,732,018 | - |
| 105 | VIR | Vir Biotechnology, Inc. | 1.91B | -3.83% | 1,269,912 | 303.23M |
| 106 | ABSI | Absci Corporation | 1.91B | -8.02% | 4,565,919 | 1.56M |
| 107 | ADRX | ADARx Pharmaceuticals, Inc. | 1.90B | -4.76% | 542,258 | 6.13M |
| 108 | TRAX | First Tracks Biotherapeutics, Inc. | 1.89B | -0.33% | 434,123 | - |
| 109 | GENB | Generate Biomedicines, Inc. | 1.86B | -8.31% | 1,170,814 | 26.48M |
| 110 | ZBIO | Zenas BioPharma, Inc. | 1.85B | -1.29% | 358,069 | 1.00M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.82B | -17.94% | 3,094,695 | 98.34M |
| 112 | BRVE | Braveheart Bio, Inc. | 1.76B | 1.51% | 533,666 | - |
| 113 | NTLA | Intellia Therapeutics, Inc. | 1.75B | -5.74% | 4,087,704 | 59.51M |
| 114 | QURE | uniQure N.V. | 1.72B | -1.86% | 1,895,412 | 18.67M |
| 115 | STOK | Stoke Therapeutics, Inc. | 1.70B | -0.23% | 1,856,808 | 28.21M |
| 116 | MAZE | Maze Therapeutics, Inc. | 1.70B | -1.41% | 327,123 | 20.00M |
| 117 | NUVB | Nuvation Bio Inc. | 1.67B | -0.21% | 5,063,516 | 169.90M |
| 118 | REPL | Replimune Group, Inc. | 1.67B | 1.27% | 3,853,051 | - |
| 119 | KLRA | Kailera Therapeutics, Inc. | 1.67B | -4.10% | 868,347 | - |
| 120 | NVAX | Novavax, Inc. | 1.66B | -3.72% | 4,061,663 | 413.80M |
| 121 | MLYS | Mineralys Therapeutics, Inc. | 1.61B | -14.41% | 3,979,573 | - |
| 122 | URGN | UroGen Pharma Ltd. | 1.60B | -2.27% | 1,167,545 | 188.73M |
| 123 | NBTX | Nanobiotix S.A. | 1.60B | -7.19% | 235,667 | 13.15M |
| 124 | RARE | Ultragenyx Pharmaceutical Inc. | 1.58B | -4.05% | 2,334,108 | 717.00M |
| 125 | IMCR | Immunocore Holdings plc | 1.57B | -2.49% | 290,226 | 430.78M |
| 126 | GPCR | Structure Therapeutics Inc. | 1.56B | -0.32% | 696,973 | - |
| 127 | INVA | Innoviva, Inc. | 1.53B | -0.42% | 623,244 | 440.00M |
| 128 | OCUL | Ocular Therapeutix, Inc. | 1.53B | -4.65% | 2,629,732 | 52.06M |
| 129 | LYCA | Lycia Therapeutics, Inc. | 1.52B | -4.80% | 202,423 | 4.44M |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.45B | -1.91% | 625,768 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.44B | -0.74% | 293,611 | 106.09M |
| 132 | GHRS | GH Research PLC | 1.43B | -2.98% | 305,383 | - |
| 133 | KRSA | Korsana Biosciences, Inc. | 1.37B | -0.26% | 104,183 | - |
| 134 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | -2.13% | 1,501,134 | 5.49M |
| 135 | OMER | Omeros Corporation | 1.33B | -2.69% | 885,576 | 38.42M |
| 136 | NKTR | Nektar Therapeutics | 1.33B | -0.79% | 600,920 | 54.59M |
| 137 | DMRA | Damora Therapeutics, Inc. | 1.33B | -2.36% | 339,515 | - |
| 138 | KARD | Kardigan, Inc. | 1.32B | -1.26% | 452,782 | - |
| 139 | LBRX | LB Pharmaceuticals Inc | 1.28B | -1.12% | 428,898 | - |
| 140 | AAPG | Ascentage Pharma Group International | 1.27B | -2.85% | 15,918 | 94.61M |
| 141 | SVRA | Savara Inc. | 1.22B | -2.63% | 1,412,059 | - |
| 142 | SNDX | Syndax Pharmaceuticals, Inc. | 1.22B | -3.53% | 2,539,579 | 252.25M |
| 143 | DRTS | Alpha Tau Medical Ltd. | 1.21B | -1.28% | 475,222 | - |
| 144 | RAPP | Rapport Therapeutics, Inc. | 1.20B | 3.47% | 926,555 | 20.00M |
| 145 | SLN | Silence Therapeutics plc | 1.19B | -0.25% | 621,426 | 615.00K |
| 146 | VSTM | Verastem, Inc. | 1.18B | 0.93% | 2,411,803 | 87.53M |
| 147 | VOR | Vor Biopharma Inc. | 1.16B | -5.88% | 759,593 | - |
| 148 | AVLN | Avalyn Pharma Inc. | 1.14B | -0.31% | 343,494 | - |
| 149 | MNKD | MannKind Corporation | 1.13B | - | 2,009,438 | 393.63M |
| 150 | SGP | SpyGlass Pharma, Inc. | 1.08B | -0.83% | 94,144 | - |
| 151 | JANX | Janux Therapeutics, Inc. | 1.07B | -2.02% | 540,001 | 24.00M |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.06B | -2.54% | 438,815 | 1.30M |
| 153 | SPTX | Seaport Therapeutics, Inc. | 1.05B | -7.11% | 549,189 | - |
| 154 | CTY | City Therapeutics, Inc. | 1.03B | -6.46% | 116,775 | 14.34M |
| 155 | MLTX | MoonLake Immunotherapeutics | 1.00B | -6.28% | 1,128,536 | - |
| 156 | IMTX | Immatics N.V. | 984.17M | -1.50% | 1,715,851 | 47.65M |
| 157 | CGEM | Cullinan Therapeutics, Inc. | 967.25M | -2.72% | 389,408 | - |
| 158 | RIGL | Rigel Pharmaceuticals, Inc. | 958.46M | -0.27% | 174,404 | 276.79M |
| 159 | ORIC | ORIC Pharmaceuticals, Inc. | 957.75M | 2.78% | 2,441,588 | - |
| 160 | ODTX | Odyssey Therapeutics, Inc. | 936.33M | -1.46% | 166,394 | 99.00K |
| 161 | LTGO | Latigo Biotherapeutics, Inc. | 924.88M | -10.23% | 216,168 | - |
| 162 | GLUE | Monte Rosa Therapeutics, Inc. | 917.97M | -1.01% | 1,348,181 | 28.73M |
| 163 | OBX | Obsidian Therapeutics, Inc. | 913.62M | 1.86% | 563,007 | - |
| 164 | KURA | Kura Oncology, Inc. | 912.74M | -2.84% | 2,252,491 | 77.23M |
| 165 | MGTX | MeiraGTx Holdings plc | 911.45M | -2.27% | 452,162 | 397.50M |
| 166 | JBIO | Jade Biosciences, Inc. | 894.18M | -1.26% | 682,298 | - |
| 167 | ANRO | Alto Neuroscience, Inc. | 886.87M | -3.71% | 484,412 | - |
| 168 | AKTS | Aktis Oncology, Inc. | 886.02M | -5.46% | 251,536 | 10.06M |
| 169 | ALMS | Alumis Inc. | 871.10M | -2.32% | 2,236,895 | 7.40M |
| 170 | PHAR | Pharming Group N.V. | 861.02M | 0.82% | 14,047 | 386.75M |
| 171 | CRVS | Corvus Pharmaceuticals, Inc. | 843.73M | -1.96% | 845,072 | - |
| 172 | PRME | Prime Medicine, Inc. | 839.71M | -9.92% | 6,569,454 | 4.07M |
| 173 | IVA | Inventiva S.A. | 838.96M | -2.14% | 1,728,967 | 2.81M |
| 174 | ABUS | Arbutus Biopharma Corporation | 832.94M | -1.64% | 2,526,139 | 181.72M |
| 175 | HELP | Helus Pharma Inc. | 774.07M | -1.07% | 1,146,327 | - |
| 176 | SANA | Sana Biotechnology, Inc. | 769.36M | -5.51% | 2,076,876 | - |
| 177 | ANNX | Annexon, Inc. | 767.80M | 1.00% | 2,840,292 | - |
| 178 | BBTX | Bambusa Therapeutics, Inc. | 763.63M | -6.31% | 2,198,886 | - |
| 179 | ARDX | Ardelyx, Inc. | 755.04M | -2.26% | 3,625,875 | 450.89M |
| 180 | DNA | Ginkgo Bioworks Holdings, Inc. | 754.88M | -12.01% | 2,730,259 | 132.42M |
| 181 | OABI | OmniAb, Inc. | 745.35M | -2.29% | 2,113,998 | 40.21M |
| 182 | AVBP | ArriVent BioPharma, Inc. | 733.21M | -6.77% | 1,194,836 | - |
| 183 | WVE | Wave Life Sciences, Inc. | 708.05M | -1.10% | 3,330,982 | 70.92M |
| 184 | SGMT | Sagimet Biosciences Inc. | 703.41M | -4.89% | 989,107 | - |
| 185 | ACHV | Achieve Life Sciences, Inc. | 702.82M | -5.01% | 1,376,718 | - |
| 186 | ATTO | Attovia Therapeutics, Inc. | 693.44M | -0.52% | 146,673 | 1.80M |
| 187 | SLBT | SL Science Holding Limited | 684.32M | 2.56% | 26,608 | 3.27M |
| 188 | APMD | Apnimed, Inc. | 682.74M | -5.42% | 466,517 | 115.12M |
| 189 | DSGN | Design Therapeutics, Inc. | 668.37M | -3.44% | 249,544 | - |
| 190 | SLDB | Solid Biosciences Inc. | 664.80M | -2.97% | 873,117 | - |
| 191 | FDMT | 4D Molecular Therapeutics, Inc. | 657.41M | -6.89% | 683,476 | 92.01M |
| 192 | CADL | Candel Therapeutics, Inc. | 637.40M | -3.70% | 779,842 | - |
| 193 | AURA | Aura Biosciences, Inc. | 636.75M | -2.54% | 533,005 | - |
| 194 | IMMX | Immix Biopharma, Inc. | 636.69M | -3.76% | 1,382,222 | - |
| 195 | IAM | Iambic Therapeutics, Inc. | 636.59M | -5.95% | 476,853 | 18.25M |
| 196 | LXRX | Lexicon Pharmaceuticals, Inc. | 631.84M | -4.05% | 2,444,205 | 41.47M |
| 197 | ACRS | Aclaris Therapeutics, Inc. | 615.29M | -0.50% | 1,880,494 | 8.22M |
| 198 | ANL | Adlai Nortye Group Ltd. | 615.00M | -7.10% | 262,097 | 18.06M |
| 199 | OLMA | Olema Pharmaceuticals, Inc. | 612.48M | -4.50% | 751,361 | - |
| 200 | ZVRA | Zevra Therapeutics, Inc. | 610.47M | -0.77% | 642,042 | 136.07M |
| 201 | BCAX | Bicara Therapeutics Inc. | 604.16M | -6.17% | 4,195,966 | - |
| 202 | NVCT | Nuvectis Pharma, Inc. | 602.11M | -0.48% | 168,802 | - |
| 203 | CLYM | Climb Bio, Inc. | 588.72M | -0.77% | 708,748 | - |
| 204 | CBIO | Crescent Biopharma, Inc. | 576.96M | -4.19% | 189,512 | 11.88M |
| 205 | GERN | Geron Corporation | 574.63M | -5.47% | 18,809,147 | 204.56M |
| 206 | MDXG | MiMedx Group, Inc. | 566.19M | -2.27% | 2,124,736 | 303.73M |
| 207 | DBVT | DBV Technologies S.A. | 561.70M | -7.77% | 410,565 | 3.76M |
| 208 | STTK | Shattuck Labs, Inc. | 558.02M | -2.80% | 951,481 | 1.00M |
| 209 | ENTX | Entera Bio Ltd. | 556.55M | 2.56% | 292,681 | 42.00K |
| 210 | NGNE | Neurogene Inc. | 551.31M | -4.41% | 248,992 | 925.00K |
| 211 | DRUG | Bright Minds Biosciences Inc. | 544.36M | -3.02% | 95,814 | - |
| 212 | PBYI | Puma Biotechnology, Inc. | 538.91M | -0.95% | 339,536 | 231.24M |
| 213 | VALN | Valneva SE | 519.43M | -4.55% | 7,929 | 163.30M |
| 214 | ARVN | Arvinas, Inc. | 513.94M | -0.51% | 1,125,550 | 316.70M |
| 215 | OCS | Oculis Holding AG | 509.91M | 0.24% | 309,697 | 1.45M |
| 216 | CTMX | CytomX Therapeutics, Inc. | 509.88M | 2.18% | 4,943,623 | 18.30M |
| 217 | ETRA | Electra Therapeutics, Inc. | 508.41M | -6.25% | 150,482 | - |
| 218 | SRZN | Surrozen, Inc. | 508.06M | -1.43% | 231,860 | 11.51M |
| 219 | DMAC | DiaMedica Therapeutics Inc. | 498.81M | -2.84% | 174,646 | - |
| 220 | OVID | Ovid Therapeutics Inc. | 496.06M | -0.78% | 3,145,476 | 1.58M |
| 221 | GYRE | Gyre Therapeutics, Inc. | 482.98M | -28.94% | 394,071 | 109.82M |
| 222 | FTH | Faeth Therapeutics, Inc. | 482.96M | -0.32% | 509,940 | - |
| 223 | RGNX | REGENXBIO Inc. | 475.29M | -2.83% | 1,061,581 | 174.48M |
| 224 | INDP | Indaptus Therapeutics, Inc. | 474.57M | -7.49% | 241,848 | - |
| 225 | MNPR | Monopar Therapeutics Inc. | 472.00M | -2.21% | 197,763 | - |
| 226 | PHAT | Phathom Pharmaceuticals, Inc. | 455.93M | -7.72% | 1,619,617 | 274.88M |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 449.68M | -5.79% | 1,222,988 | - |
| 228 | CRMD | CorMedix Inc. | 443.89M | -25.46% | 7,284,771 | 462.25M |
| 229 | BLSM | BlossomHill Therapeutics, Inc. | 437.04M | -9.60% | 156,294 | - |
| 230 | PRTA | Prothena Corporation plc | 434.82M | -4.62% | 452,298 | 54.53M |
| 231 | ASPE | Aspen Neuroscience, Inc. | 432.98M | -0.73% | 1,322,403 | - |
| 232 | MPLT | MapLight Therapeutics, Inc. | 421.26M | -1.81% | 394,981 | - |
| 233 | YDES | YD Bio Limited | 420.74M | 1.19% | 47,347 | 1.24M |
| 234 | CCCC | C4 Therapeutics, Inc. | 414.59M | 2.12% | 2,354,062 | 35.04M |
| 235 | RZLT | Rezolute, Inc. | 414.34M | -4.13% | 779,188 | - |
| 236 | EDIT | Editas Medicine, Inc. | 410.06M | -8.87% | 2,909,128 | 47.01M |
| 237 | ASMB | Assembly Biosciences, Inc. | 409.86M | -3.50% | 136,864 | 74.85M |
| 238 | ALLO | Allogene Therapeutics, Inc. | 407.68M | -5.60% | 9,759,507 | 4.64M |
| 239 | AUTL | Autolus Therapeutics plc | 404.57M | -3.80% | 1,675,288 | 117.39M |
| 240 | PRLD | Prelude Therapeutics Incorporated | 399.62M | -5.37% | 218,103 | 22.42M |
| 241 | ALT | Altimmune, Inc. | 396.82M | -4.67% | 3,519,849 | 31.00K |
| 242 | PROK | ProKidney Corp. | 391.51M | -11.90% | 1,730,405 | 818.00K |
| 243 | ZURA | Zura Bio Limited | 389.15M | 4.94% | 4,078,514 | - |
| 244 | TECX | Tectonic Therapeutic, Inc. | 386.69M | -3.51% | 146,255 | - |
| 245 | AVTX | Avalo Therapeutics, Inc. | 384.53M | -3.63% | 1,534,516 | 59.00K |
| 246 | RLMD | Relmada Therapeutics, Inc. | 381.88M | 4.07% | 1,413,727 | - |
| 247 | CAPR | Capricor Therapeutics, Inc. | 370.93M | -3.77% | 3,357,108 | 11.13M |
| 248 | TRXB | TRex Bio, Inc. | 369.91M | 1.63% | 39,169 | - |
| 249 | AGMB | AgomAb Therapeutics NV | 368.87M | -5.79% | 197,833 | - |
| 250 | FENC | Fennec Pharmaceuticals Inc. | 359.09M | -6.48% | 195,650 | 59.22M |
| 251 | OBIO | Orchestra BioMed Holdings, Inc. | 355.22M | -2.96% | 231,573 | 31.98M |
| 252 | CTNM | Contineum Therapeutics, Inc. | 353.26M | 0.64% | 458,621 | - |
| 253 | KYTX | Kyverna Therapeutics, Inc. | 350.65M | -3.08% | 640,116 | - |
| 254 | NAUT | Nautilus Biotechnology, Inc. | 347.73M | -13.06% | 8,068,898 | 424.00K |
| 255 | SPRY | ARS Pharmaceuticals, Inc. | 336.13M | -7.65% | 1,756,861 | 116.93M |
| 256 | GALT | Galectin Therapeutics Inc. | 334.82M | -5.68% | 174,735 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 332.14M | -0.30% | 706,226 | 15.85M |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 329.64M | -4.64% | 349,847 | - |
| 259 | ALEC | Alector, Inc. | 327.65M | -1.34% | 1,111,241 | 13.86M |
| 260 | ARCT | Arcturus Therapeutics Holdings Inc. | 313.51M | -9.22% | 1,845,015 | 29.37M |
| 261 | VTVT | vTv Therapeutics Inc. | 312.73M | -4.59% | 14,217 | 36.84M |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 311.93M | -3.95% | 202,332 | 65.26M |
| 263 | TTRX | Turn Therapeutics Inc. | 310.69M | -2.71% | 137,075 | - |
| 264 | AGEN | Agenus Inc. | 307.94M | -3.53% | 564,300 | 132.69M |
| 265 | IRD | Opus Genetics, Inc. | 305.33M | 0.55% | 1,020,098 | 9.86M |
| 266 | BNTC | Benitec Biopharma Inc. | 304.88M | -1.02% | 135,479 | - |
| 267 | SABS | SAB Biotherapeutics, Inc. | 304.80M | 3.72% | 741,039 | 114.70K |
| 268 | VOGX | Vogenx, Inc. | 300.82M | 1.66% | 45,083 | - |
| 269 | SCTX | Scribe Therapeutics Inc. | 291.93M | -11.58% | 480,710 | 33.30M |
| 270 | EIKN | Eikon Therapeutics, Inc. | 287.62M | -0.75% | 553,126 | - |
| 271 | FULC | Fulcrum Therapeutics, Inc. | 283.06M | -1.59% | 933,217 | 80.00M |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 282.22M | -7.19% | 438,286 | 1.00 |
| 273 | VCRE | Vicore Pharma Holding AB (publ) | 277.97M | -3.92% | 11,889 | 412.09K |
| 274 | LYEL | Lyell Immunopharma, Inc. | 270.54M | -2.39% | 113,256 | 27.00K |
| 275 | RCKT | Rocket Pharmaceuticals, Inc. | 267.85M | -3.94% | 1,535,015 | - |
| 276 | IPSC | Century Therapeutics, Inc. | 266.18M | 0.68% | 951,160 | 109.16M |
| 277 | QTTB | Q32 Bio Inc. | 265.25M | 0.45% | 268,078 | 53.74M |
| 278 | LRMR | Larimar Therapeutics, Inc. | 257.83M | -7.49% | 781,223 | - |
| 279 | LXEO | Lexeo Therapeutics, Inc. | 257.61M | 2.61% | 1,001,519 | - |
| 280 | BCYC | Bicycle Therapeutics plc | 256.17M | -4.19% | 348,481 | 83.53M |
| 281 | CUVL | Clinuvel Pharmaceuticals Limited | 256.15M | -1.55% | 5,185 | 65.05M |
| 282 | CABA | Cabaletta Bio, Inc. | 256.01M | -4.73% | 3,757,080 | - |
| 283 | GLSI | Greenwich LifeSciences, Inc. | 255.55M | -8.37% | 174,560 | - |
| 284 | LCTX | Lineage Cell Therapeutics, Inc. | 252.91M | -2.91% | 1,166,443 | 13.08M |
| 285 | FATE | Fate Therapeutics, Inc. | 249.23M | -4.15% | 1,064,293 | 6.49M |
| 286 | ABEO | Abeona Therapeutics Inc. | 248.75M | -4.61% | 783,430 | 25.52M |
| 287 | CAMP | Camp4 Therapeutics Corporation | 248.50M | 1.54% | 137,898 | 4.22M |
| 288 | IFRX | InflaRx N.V. | 244.63M | -3.21% | 691,363 | -11.54K |
| 289 | EVMN | Evommune, Inc. | 244.25M | -1.17% | 586,352 | 10.00M |
| 290 | IMRX | Immuneering Corporation | 242.29M | -6.84% | 1,138,840 | - |
| 291 | OCGN | Ocugen, Inc. | 238.29M | -5.58% | 5,423,946 | 4.58M |
| 292 | VNDA | Vanda Pharmaceuticals Inc. | 229.18M | -6.42% | 1,793,406 | 229.28M |
| 293 | ELDN | Eledon Pharmaceuticals, Inc. | 225.32M | -8.88% | 1,265,071 | - |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 223.78M | -0.45% | 33,517 | 1.80M |
| 295 | ACIU | AC Immune SA | 220.73M | -6.33% | 105,014 | 21.67M |
| 296 | KROS | Keros Therapeutics, Inc. | 218.89M | -2.82% | 120,153 | 15.01M |
| 297 | PYXS | Pyxis Oncology, Inc. | 216.22M | -4.23% | 686,527 | 11.04M |
| 298 | KRRO | Korro Bio, Inc. | 210.80M | 0.81% | 130,745 | 2.38M |
| 299 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 210.06M | -2.96% | 314,785 | - |
| 300 | PLX | Protalix BioTherapeutics, Inc. | 208.68M | -0.77% | 249,288 | 80.62M |
| 301 | ARTV | Artiva Biotherapeutics, Inc. | 204.85M | -0.95% | 1,966,165 | 251.00K |
| 302 | PALI | Palisade Bio, Inc. | 202.15M | -2.52% | 3,090,497 | 500.00K |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 196.36M | -3.85% | 78,798 | 1.48M |
| 304 | PRQR | ProQR Therapeutics N.V. | 196.16M | -3.47% | 795,034 | 21.05M |
| 305 | DTIL | Precision BioSciences, Inc. | 194.87M | -5.11% | 108,824 | 45.06M |
| 306 | ACOG | Alpha Cognition Inc. | 190.34M | -4.90% | 48,323 | 15.26M |
| 307 | CGEN | Compugen Ltd. | 187.55M | -2.94% | 255,448 | 74.00M |
| 308 | UPB | Upstream Bio, Inc. | 186.77M | 4.28% | 946,122 | 3.16M |
| 309 | ZNTL | Zentalis Pharmaceuticals, Inc. | 185.56M | -1.51% | 1,332,472 | 26.87M |
| 310 | YARW | Yarrow Bioscience, Inc. | 185.16M | -0.50% | 288,946 | - |
| 311 | WHWK | Whitehawk Therapeutics, Inc. | 184.71M | -1.82% | 153,346 | 7.15M |
| 312 | SION | Sionna Therapeutics, Inc. | 174.97M | -3.25% | 534,344 | - |
| 313 | MDWD | MediWound Ltd. | 171.71M | -4.04% | 110,075 | 11.86M |
| 314 | IVVD | Invivyd, Inc. | 171.46M | -3.37% | 5,379,088 | 58.37M |
| 315 | ORMP | Oramed Pharmaceuticals Inc. | 170.97M | -2.84% | 91,498 | 2.00M |
| 316 | ANTX | AN2 Therapeutics, Inc. | 170.95M | -3.41% | 284,722 | - |
| 317 | ALXO | ALX Oncology Holdings Inc. | 168.70M | - | 422,202 | - |
| 318 | ADAG | Adagene Inc. | 168.53M | -6.34% | 79,691 | 9.29M |
| 319 | TRDA | Entrada Therapeutics, Inc. | 163.52M | 3.07% | 317,344 | 4.69M |
| 320 | PEPG | PepGen Inc. | 163.45M | -2.07% | 1,129,063 | - |
| 321 | VRXA | Veraxa Biotech AG | 161.20M | 0.88% | 261,428 | 29.54K |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 155.38M | -4.88% | 533,005 | 1.50M |
| 323 | MGNX | MacroGenics, Inc. | 152.88M | 0.84% | 1,182,939 | 175.14M |
| 324 | CUE | Cue Biopharma, Inc. | 151.61M | -2.70% | 60,770 | 37.66M |
| 325 | STRO | Sutro Biopharma, Inc. | 150.89M | -0.44% | 122,287 | 45.70M |
| 326 | NGEN | NervGen Pharma Corp. | 147.31M | -4.86% | 546,938 | - |
| 327 | TARA | Protara Therapeutics, Inc. | 146.56M | -1.59% | 581,160 | - |
| 328 | MSLE | Satellos Bioscience Inc. | 145.06M | -1.76% | 30,766 | - |
| 329 | CMPX | Compass Therapeutics, Inc. | 141.64M | 4.01% | 2,918,227 | 850.00K |
| 330 | RNA | Atrium Therapeutics, Inc. | 141.46M | 0.12% | 566,621 | 35.84M |
| 331 | MENS | Jyong Biotech Ltd. | 139.56M | - | 18,776 | - |
| 332 | NBP | NovaBridge Biosciences | 138.62M | -1.24% | 583,220 | - |
| 333 | MOLN | Molecular Partners AG | 134.38M | 1.42% | 1,752 | 856.30K |
| 334 | SPRB | Spruce Biosciences, Inc. | 133.33M | -0.92% | 65,957 | 697.00K |
| 335 | IPHA | Innate Pharma S.A. | 131.41M | -2.67% | 14,784 | 11.21M |
| 336 | CDXS | Codexis, Inc. | 130.31M | -2.46% | 789,437 | 77.68M |
| 337 | CHRS | Coherus Oncology, Inc. | 128.25M | -7.60% | 2,193,767 | 50.94M |
| 338 | FHTX | Foghorn Therapeutics Inc. | 123.52M | -0.48% | 555,596 | 36.74M |
| 339 | HURA | TuHURA Biosciences, Inc. | 122.99M | -6.31% | 524,065 | - |
| 340 | ARMP | Armata Pharmaceuticals, Inc. | 121.96M | 0.92% | 46,741 | 5.54M |
| 341 | KZIA | Kazia Therapeutics Limited | 116.48M | -2.52% | 230,435 | 1.27M |
| 342 | HUMA | Humacyte, Inc. | 114.23M | -12.47% | 5,119,874 | 2.12M |
| 343 | OTLK | Outlook Therapeutics, Inc. | 113.96M | -5.15% | 4,794,518 | -1.16M |
| 344 | NKTX | Nkarta, Inc. | 111.73M | -6.02% | 1,214,432 | - |
| 345 | NERV | Minerva Neurosciences, Inc. | 110.77M | 3.57% | 394,690 | - |
| 346 | AVXL | Anavex Life Sciences Corp. | 110.31M | -8.46% | 1,198,059 | - |
| 347 | PYPD | PolyPid Ltd. | 109.48M | -3.58% | 101,255 | - |
| 348 | ANIX | Anixa Biosciences, Inc. | 108.46M | -5.45% | 140,607 | - |
| 349 | EQ | Equillium, Inc. | 107.36M | -3.52% | 310,723 | 4.39M |
| 350 | OKUR | OnKure Therapeutics, Inc. | 106.10M | - | 306,757 | - |
| 351 | VYGR | Voyager Therapeutics, Inc. | 105.98M | -2.27% | 878,823 | 34.46M |
| 352 | PDSB | PDS Biotechnology Corporation | 104.36M | -7.10% | 5,547,034 | - |
| 353 | UNCY | Unicycive Therapeutics, Inc. | 104.18M | -1.84% | 1,300,297 | - |
| 354 | MIST | Milestone Pharmaceuticals Inc. | 102.86M | -7.55% | 730,164 | 2.34M |
| 355 | ENGN | enGene Therapeutics Inc. | 102.53M | - | 1,197,769 | - |
| 356 | TENX | Tenax Therapeutics, Inc. | 102.53M | -3.76% | 888,064 | - |
| 357 | IMUX | Immunic, Inc. | 102.47M | -3.72% | 244,421 | - |
| 358 | TLSA | Tiziana Life Sciences Ltd | 102.42M | -11.57% | 1,292,063 | - |
| 359 | BDTX | Black Diamond Therapeutics, Inc. | 102.27M | -4.30% | 520,157 | 70.00M |
| 360 | PMVP | PMV Pharmaceuticals, Inc. | 98.92M | -2.96% | 1,212,844 | - |
| 361 | CBUS | Cibus, Inc. | 98.59M | -4.44% | 52,976 | 4.35M |
| 362 | VANI | Vivani Medical, Inc. | 98.32M | -4.39% | 199,263 | - |
| 363 | NRXP | NRx Pharmaceuticals, Inc. | 98.21M | -14.66% | 15,641,562 | 3.39M |
| 364 | LENZ | LENZ Therapeutics, Inc. | 95.83M | -12.61% | 2,264,190 | 12.36M |
| 365 | RTSN | Retension Pharmaceuticals, Inc. | 94.65M | -3.97% | 58,698 | - |
| 366 | GNLX | Genelux Corporation | 93.21M | -0.95% | 209,582 | 8.00K |
| 367 | ICCC | ImmuCell Corporation | 93.18M | -0.58% | 11,020 | 30.68M |
| 368 | SEER | Seer, Inc. | 93.02M | -13.40% | 516,538 | 14.22M |
| 369 | TVGN | Tevogen Inc. | 92.85M | -2.48% | 2,991 | - |
| 370 | NRXS | NeurAxis, Inc. | 89.54M | -5.56% | 150,385 | 5.32M |
| 371 | TNXP | Tonix Pharmaceuticals Holding Corp. | 87.47M | -3.41% | 567,063 | 29.10M |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 87.23M | -5.91% | 32,570 | - |
| 373 | COYA | Coya Therapeutics, Inc. | 84.68M | -9.30% | 214,740 | 8.02M |
| 374 | CLLS | Cellectis S.A. | 84.26M | -7.69% | 12,217 | 63.82M |
| 375 | RLYB | Rallybio Corporation | 83.67M | 0.84% | 61,712 | 434.00K |
| 376 | TNYA | Tenaya Therapeutics, Inc. | 82.38M | -7.78% | 2,657,950 | 1.34M |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 82.24M | -2.54% | 714,342 | 4.88M |
| 378 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 81.62M | - | 2,317,173 | - |
| 379 | NTHI | NeOnc Technologies Holdings, Inc. | 81.03M | 4.49% | 131,607 | 39.99K |
| 380 | ATRA | Atara Biotherapeutics, Inc. | 80.40M | -6.10% | 29,930 | 6.19M |
| 381 | CNXU | Conexeu Sciences Inc. | 78.31M | -10.25% | 518,706 | - |
| 382 | OKYO | OKYO Pharma Limited | 77.14M | -2.00% | 107,513 | - |
| 383 | NTRB | Nutriband Inc. | 76.58M | -5.12% | 22,233 | 1.62M |
| 384 | CING | Cingulate Inc. | 72.42M | -4.05% | 75,642 | - |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 71.14M | -5.68% | 165,728 | - |
| 386 | CRDF | Cardiff Oncology, Inc. | 69.21M | -2.46% | 126,854 | 508.00K |
| 387 | NMRA | Neumora Therapeutics, Inc. | 69.00M | -5.43% | 1,107,523 | - |
| 388 | MNOV | MediciNova, Inc. | 68.91M | - | 25,214 | 920.48K |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 68.85M | -3.01% | 96,698 | - |
| 390 | CSBR | Champions Oncology, Inc. | 66.95M | - | 8,439 | 60.66M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 66.91M | -6.78% | 313,656 | - |
| 392 | CGTX | Cognition Therapeutics, Inc. | 66.39M | -5.57% | 557,756 | - |
| 393 | FBIO | Fortress Biotech, Inc. | 64.03M | -4.00% | 196,838 | 68.47M |
| 394 | GOSS | Gossamer Bio, Inc. | 63.49M | -2.90% | 179,463 | 53.29M |
| 395 | INO | Inovio Pharmaceuticals, Inc. | 62.29M | -21.95% | 80,500,974 | 65.34K |
| 396 | SPRO | Spero Therapeutics, Inc. | 61.73M | -4.50% | 309,863 | 47.00M |
| 397 | RNXT | RenovoRx, Inc. | 60.02M | -10.74% | 376,367 | 1.98M |
| 398 | RNTX | Rein Therapeutics Inc. | 57.80M | -7.79% | 121,461 | - |
| 399 | VRCA | Verrica Pharmaceuticals Inc. | 57.55M | -2.05% | 33,786 | 30.32M |
| 400 | XBIT | XBiotech Inc. | 57.32M | -3.09% | 50,560 | - |
| 401 | OSTX | OS Therapies Incorporated | 57.29M | -4.62% | 321,725 | - |
| 402 | BOLD | Boundless Bio, Inc. | 56.18M | -0.40% | 47,014 | - |
| 403 | CLNN | Clene Inc. | 54.44M | -1.79% | 47,258 | 197.00K |
| 404 | ELOX | Eloxx Pharmaceuticals, Inc. | 54.29M | 1.89% | 13,988 | - |
| 405 | ONCY | Oncolytics Biotech Inc. | 54.24M | -0.54% | 764,147 | - |
| 406 | ALPS | Alps Group Inc | 54.08M | 0.03% | 36,100 | 3.74M |
| 407 | INKT | MiNK Therapeutics, Inc. | 53.73M | -3.22% | 8,681 | - |
| 408 | HYFT | MindWalk Holdings Corp. | 53.24M | -5.83% | 195,302 | 11.57M |
| 409 | PLRX | Pliant Therapeutics, Inc. | 53.18M | -0.13% | 169,524 | - |
| 410 | XLO | Xilio Therapeutics, Inc. | 52.84M | 3.35% | 7,914 | 64.09M |
| 411 | HRTX | Heron Therapeutics, Inc. | 52.72M | -5.67% | 1,426,349 | 151.18M |
| 412 | CNTB | Connect Biopharma Holdings Limited | 50.52M | -3.97% | 2,503,724 | 2.95M |
| 413 | HYPD | Hyperion DeFi, Inc. | 50.04M | -8.13% | 356,339 | 1.40M |
| 414 | IBIO | iBio, Inc. | 49.43M | -5.52% | 213,957 | 100.00K |
| 415 | GANX | Gain Therapeutics, Inc. | 49.32M | -5.04% | 364,650 | - |
| 416 | SER | Serina Therapeutics, Inc. | 49.28M | 2.65% | 155,108 | 130.00K |
| 417 | KLRS | Kalaris Therapeutics, Inc. | 48.32M | -4.69% | 60,195 | - |
| 418 | ANVS | Annovis Bio, Inc. | 48.14M | 10.78% | 1,499,353 | - |
| 419 | HOWL | Werewolf Therapeutics, Inc. | 47.92M | -10.35% | 415,476 | 21.00M |
| 420 | LONA | LeonaBio, Inc. | 46.54M | 0.61% | 43,067 | - |
| 421 | IMA | ImageneBio, Inc. | 46.54M | 1.23% | 5,671 | 800.00K |
| 422 | ATNM | Actinium Pharmaceuticals, Inc. | 46.53M | -3.27% | 157,720 | 35.09M |
| 423 | BMEA | Biomea Fusion, Inc. | 46.35M | 2.68% | 1,099,866 | - |
| 424 | MREO | Mereo BioPharma Group plc | 46.23M | -4.08% | 543,620 | 500.00K |
| 425 | TIL | Instil Bio, Inc. | 46.12M | -0.44% | 25,227 | - |
| 426 | APLM | Apollomics, Inc. | 45.44M | -0.53% | 36,516 | 8.84M |
| 427 | CRBU | Caribou Biosciences, Inc. | 45.37M | -4.90% | 2,306,242 | 10.04M |
| 428 | INMB | INmune Bio Inc. | 44.59M | -9.38% | 184,099 | 50.00K |
| 429 | ELTX | Elicio Therapeutics, Inc. | 44.15M | -4.00% | 183,885 | - |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 43.51M | 4.07% | 62,216 | - |
| 431 | ATHE | Alterity Therapeutics Limited | 42.71M | -3.31% | 9,051 | 2.50M |
| 432 | GRCE | Grace Therapeutics, Inc. | 40.81M | - | 85,938 | - |
| 433 | EXOZ | eXoZymes, Inc. | 38.33M | 0.49% | 6,112 | -700.00 |
| 434 | VERU | Veru Inc. | 37.34M | -1.79% | 78,873 | 16.89M |
| 435 | ACET | Adicet Bio, Inc. | 36.81M | -4.47% | 242,464 | - |
| 436 | PTHS | Pelthos Therapeutics Inc. | 35.99M | -43.17% | 242,032 | 43.30M |
| 437 | GRDX | GridAI Technologies Corp. | 35.12M | -8.99% | 147,059 | - |
| 438 | EDSA | Edesa Biotech, Inc. | 34.72M | -4.81% | 30,624 | - |
| 439 | LITS | Lite Strategy, Inc. | 34.06M | -4.27% | 270,384 | - |
| 440 | NNVC | NanoViricides, Inc. | 33.95M | -6.99% | 224,298 | - |
| 441 | ALDX | Aldeyra Therapeutics, Inc. | 33.80M | -14.99% | 896,537 | - |
| 442 | IRLA | IRulya Therapeutics Inc. | 33.51M | 4.21% | 97,994 | - |
| 443 | IBO | Impact BioMedical Inc. | 32.47M | -1.81% | 15,292 | 35.00K |
| 444 | FLNA | Filana Therapeutics, Inc. | 30.05M | -5.47% | 215,071 | - |
| 445 | EYPT | EyePoint, Inc. | 30.04M | -8.32% | 6,118,895 | 2.79M |
| 446 | ALGS | Aligos Therapeutics, Inc. | 29.97M | -4.57% | 23,741 | 31.52M |
| 447 | AARD | Aardvark Therapeutics, Inc. | 29.76M | -5.56% | 467,601 | - |
| 448 | PMN | ProMIS Neurosciences, Inc. | 29.68M | -70.13% | 1,639,768 | - |
| 449 | MGX | Metagenomi Therapeutics, Inc. | 29.48M | -6.01% | 77,876 | 13.56M |
| 450 | NXTC | NextCure, Inc. | 28.88M | -3.37% | 19,106 | - |
| 451 | ESLA | Estrella Immunopharma, Inc. | 27.81M | -12.27% | 165,561 | - |
| 452 | RNAZ | TransCode Therapeutics, Inc. | 27.60M | -5.78% | 16,185 | - |
| 453 | BCTX | BriaCell Therapeutics Corp. | 26.81M | -8.16% | 130,627 | - |
| 454 | BYSI | BeyondSpring Inc. | 26.47M | 24.60% | 219,028 | 1.88M |
| 455 | PLRZ | Polyrizon Ltd. | 26.11M | 19.44% | 46,215 | - |
| 456 | ABVC | ABVC BioPharma, Inc. | 25.96M | -3.85% | 20,203 | 797.92K |
| 457 | CELU | Celularity Inc. | 25.96M | -5.79% | 181,847 | 18.67M |
| 458 | EVAX | Evaxion A/S | 24.44M | -4.87% | 46,193 | 7.49M |
| 459 | CVM | CEL-SCI Corporation | 24.27M | -8.00% | 189,970 | - |
| 460 | CRVO | CervoMed Inc. | 24.19M | -8.57% | 585,326 | 331.30K |
| 461 | IMMP | Immutep Limited | 23.85M | -8.11% | 10,586 | 13.79M |
| 462 | QNRX | Quoin Pharmaceuticals, Ltd. | 21.81M | 9.40% | 36,564 | - |
| 463 | ATOS | Atossa Therapeutics, Inc. | 21.66M | -2.69% | 32,882 | - |
| 464 | BSEM | BioStem Technologies, Inc. | 20.81M | -13.18% | 145,595 | 34.59M |
| 465 | QNTM | Quantum BioPharma Ltd. | 20.15M | -2.46% | 76,740 | - |
| 466 | COCP | Cocrystal Pharma, Inc. | 19.17M | 1.53% | 62,763 | 330.00K |
| 467 | IGC | IGC Pharma, Inc. | 19.13M | -7.13% | 523,101 | 1.11M |
| 468 | AKTX | Akari Therapeutics, Plc | 18.83M | 3.00% | 45,654 | - |
| 469 | KYNB | Kyntra Bio, Inc. | 18.50M | -1.72% | 24,415 | 4.62M |
| 470 | ACTU | Actuate Therapeutics, Inc. | 18.43M | -9.68% | 489,470 | - |
| 471 | MCRB | Seres Therapeutics, Inc. | 17.78M | -9.23% | 120,108 | 1.88M |
| 472 | CNTX | Context Therapeutics Inc. | 17.37M | -6.25% | 1,012,585 | - |
| 473 | JSPR | Jasper Therapeutics, Inc. | 17.31M | -2.22% | 396,005 | - |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 16.50M | -0.33% | 70,250 | 1.17M |
| 475 | MRKR | Marker Therapeutics, Inc. | 16.34M | -2.97% | 67,558 | 3.55M |
| 476 | PLUR | Pluri Inc. | 15.31M | 3.33% | 29,334 | 1.02M |
| 477 | RADX | Radiopharm Theranostics Limited | 15.26M | -3.23% | 8,923 | 8.90M |
| 478 | ABOS | Acumen Pharmaceuticals, Inc. | 15.20M | -90.83% | 67,906,811 | - |
| 479 | KPTI | Karyopharm Therapeutics Inc. | 15.02M | -24.76% | 3,523,426 | 146.62M |
| 480 | NCEL | NewcelX Ltd. | 14.73M | -5.27% | 11,157 | - |
| 481 | CTXR | Citius Pharmaceuticals, Inc. | 14.36M | -7.10% | 104,668 | 7.11M |
| 482 | DYAI | Dyadic International, Inc. | 13.85M | 5.32% | 113,465 | 3.80M |
| 483 | ALLR | Allarity Therapeutics, Inc. | 13.85M | -2.20% | 179,452 | 345.00K |
| 484 | DARE | Daré Bioscience, Inc. | 13.76M | 2.66% | 654,006 | 1.37M |
| 485 | AEON | AEON Biopharma, Inc. | 13.67M | -6.80% | 774,562 | - |
| 486 | BCDA | BioCardia, Inc. | 13.03M | -7.02% | 79,316 | 3.00K |
| 487 | GUTS | Fractyl Health, Inc. | 12.95M | -1.51% | 386,980 | 3.00K |
| 488 | CNSY | Cerenome, Inc. | 12.90M | -2.30% | 47,737 | 4.20M |
| 489 | BOLT | Bolt Biotherapeutics, Inc. | 12.69M | 3.62% | 249,840 | 4.70M |
| 490 | HIND | Vyome Holdings, Inc. | 12.63M | 2.86% | 42,162 | 129.73K |
| 491 | PBM | Psyence Biomedical Ltd. | 12.63M | -8.31% | 46,634 | - |
| 492 | KTTA | Pasithea Therapeutics Corp. | 12.37M | 0.16% | 100,161 | - |
| 493 | ATYR | aTyr Pharma, Inc. | 12.11M | -8.01% | 120,216 | 190.00K |
| 494 | LPCN | Lipocine Inc. | 11.87M | -5.26% | 110,405 | 1.57M |
| 495 | TCRX | TScan Therapeutics, Inc. | 11.83M | -10.47% | 333,158 | 7.11M |
| 496 | ICU | SeaStar Medical Holding Corporation | 11.78M | -3.03% | 81,708 | 1.71M |
| 497 | CLRB | Cellectar Biosciences, Inc. | 11.39M | -1.23% | 55,264 | - |
| 498 | PASG | Passage Bio, Inc. | 11.10M | -1.99% | 7,173 | - |
| 499 | INTS | Intensity Therapeutics, Inc. | 11.10M | 1.80% | 16,109 | - |
| 500 | GDTC | CytoMed Therapeutics Limited | 10.97M | 2.02% | - | 609.73K |